PDCD1 and rectal cancer: Our findings highlight distinct MRI phenotypes in MSI-H/dMMR rectal cancer after anti-PD-1 monotherapy, including persistent mucinous or intermediate T2 signal residues rather than the fibrotic T2 hypointensity seen after chemoradiation.